[DEK-DKK1-P207] Randomized Phase 2 Study of DKN-01 Plus FOLFIRI/FOLFOX and Bevacizumab Versus FOLFIRI/FOLFOX and Bevacizumab as Second-line Treatment of Advanced Colorectal Cancer (DeFianCe)
Clinical Trial Grant
Awarded By
Leap Therapeutics, Inc.
Start Date
November 4, 2022
End Date
November 6, 2027
Awarded By
Leap Therapeutics, Inc.
Start Date
November 4, 2022
End Date
November 6, 2027